STERIS plc (NYSE:STE) Shares Bought by Caden Capital Partners LP

Caden Capital Partners LP grew its holdings in STERIS plc (NYSE:STE) by 119.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 175,358 shares of the medical equipment provider’s stock after buying an additional 95,379 shares during the quarter. STERIS accounts for approximately 11.0% of Caden Capital Partners LP’s holdings, making the stock its 5th biggest holding. Caden Capital Partners LP’s holdings in STERIS were worth $36,047,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in STE. Franklin Resources Inc. increased its position in shares of STERIS by 171.2% during the 3rd quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider’s stock worth $191,370,000 after purchasing an additional 529,308 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its position in shares of STERIS by 30.8% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 10,970 shares of the medical equipment provider’s stock worth $2,275,000 after purchasing an additional 2,583 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in shares of STERIS during the 3rd quarter worth about $9,949,000. Merit Financial Group LLC acquired a new stake in STERIS in the 4th quarter valued at about $260,000. Finally, Blue Trust Inc. increased its position in STERIS by 19.9% in the 4th quarter. Blue Trust Inc. now owns 1,128 shares of the medical equipment provider’s stock valued at $232,000 after acquiring an additional 187 shares in the last quarter. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Stock Down 0.6 %

Shares of NYSE STE opened at $225.00 on Monday. The firm has a market capitalization of $22.11 billion, a PE ratio of 47.77 and a beta of 0.87. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. STERIS plc has a 1 year low of $200.98 and a 1 year high of $248.24. The firm’s 50-day moving average is $222.89 and its 200-day moving average is $218.85.

STERIS (NYSE:STE) last issued its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Equities analysts expect that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were issued a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a yield of 1.01%. The ex-dividend date of this dividend was Thursday, February 20th. STERIS’s dividend payout ratio is currently 48.41%.

Analyst Ratings Changes

Several research firms have weighed in on STE. Stephens restated an “overweight” rating and issued a $240.00 price objective on shares of STERIS in a research report on Thursday, February 6th. Piper Sandler raised their price objective on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. JMP Securities restated a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a research report on Thursday, April 10th. Finally, Needham & Company LLC restated a “hold” rating on shares of STERIS in a research report on Monday, April 7th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, STERIS currently has a consensus rating of “Moderate Buy” and a consensus price target of $258.75.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.